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Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
ABSTRACT
Background: For conventional radiotherapy treatment units, automated planning can significantly
improve plan quality. For robotic radiosurgery, systems for automatic generation of clinically deliver-
able plans do not yet exist. For prostate stereotactic body radiation therapy (SBRT), few studies have
systematically compared VMAT with robotic treatment.
Material and methods: The multi-criteria autoplanning optimizer, developed at our institute, was
coupled to the commercial treatment planning system of our robotic treatment unit, for fully
automated generation of clinically deliverable plans (autoROBOT). The system was then validated by
comparing autoROBOT plans with manually generated plans. Next, the autoROBOT system was used
for systematic comparisons between autoROBOT plans and VMAT plans, that were also automatically
generated (autoVMAT). CTV-PTV margins of 3mm were used for autoROBOT (clinical routine) and
autoVMAT plan generation. For autoVMAT, an extra plan was generated with 5mm margin (often
applied for VMAT). Plans were generated for a 4 9.5Gy fractionation scheme.
Results: Compared to manual planning, autoROBOT improved rectum D1cm3 (16%), V60GyEq (75%) and
Dmean (41%), and bladder Dmean (37%) (all p  .002), with equal PTV coverage. In the autoROBOT and
autoVMAT comparison, both with 3mm margin, rectum doses were lower for autoROBOT by 5% for
rectum D1cm3 (p¼.002), 33% for V60GyEq (p¼.001) and 4% for Dmean (p¼.05), with comparable PTV cover-
age and other OAR sparing. With 5mm margin for VMAT, 18/20 plans had a PTV coverage lower than
requested (<95%) and all plans had higher rectum doses than autoROBOT (mean percentage differen-
ces of 13% for D1cm3 , 69% for V60GyEq and 32% for Dmean (all p<.001)).
Conclusions: The first system for fully automated generation of clinically deliverable robotic plans was
built. Autoplanning did largely enhance robotic plan quality, compared to manual planning. Using
autoplanning for both the robotic system and VMAT, superiority of non-coplanar robotic treatment
compared to coplanar VMAT for prostate SBRT was demonstrated.
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Introduction
In prostate stereotactic body radiation therapy (SBRT), patients
are treated with large fraction doses, requiring high accuracy
delivery and with image-guided dose delivery [1–10]. Both C-
arm linacs [11–14] and robotic units [5–10] have been used
for prostate SBRT.
Recent findings on the potential added value of non-
coplanar setups for prostate SBRT instead of coplanar treat-
ment are contradictory [14–17]. Two recent studies have com-
pared robotic treatment and VMAT for prostate SBRT [16,17].
MacDougall et al. [16] found no discernible dosimetric differen-
ces, based on only six patients. Lin et al. [17] concluded that
VMAT was preferable because of reduced treatment time and
superior dose distribution conformality. In both studies, all
plans were generated manually, and clinically delivered plans
were retrospectively compared with an alternative plan. Both
the manual planning and retrospective comparisons may have
introduced bias and noise in the technique comparisons.
Recently, several systems have been proposed for planning
automation [18–26], all for treatment with C-arm linacs. In this
work, we have developed the first system for automatic gener-
ation of deliverable plans for non-coplanar robotic treatment
(autoROBOT). Basis of the autoROBOT planning system is a
multi-criterial optimizer that was also the core of a recently
developed system for automatic VMAT plan generation for
C-arm linacs [19,27]. The developed autoROBOT planning sys-
tem was first evaluated by comparing manually generated
prostate SBRT plans with autoROBOT plans. We then used the
autoROBOT and autoVMAT planning systems to systematically
compare robotic and VMAT treatment for prostate SBRT. The
use of exactly the same plan optimization scheme for
autoROBOT and autoVMAT (described below) allowed bias-
free technique comparisons and allowed generation of new
input for the on-going debate [14–17] on potential added
value of non-coplanar prostate SBRT, compared to copla-
nar treatment.
CONTACT Linda Rossi l.rossi@erasmusmc.nl Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
Supplemental data for this article can be accessed here.
 2018 Erasmus MC. Published by Informa UK Limited, trading as Taylor & Francis Group.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/),
which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in
any way.
ACTA ONCOLOGICA




In this study, contoured CT scans of 20 prostate SBRT patients,
previously treated with the robotic M6 CyberKnife (Accuray
Inc., Sunnyvale, CA, USA), were used. A planning target vol-
ume (PTV) with a 3mm isotropic margin around the prostate
(PTV3mm) was used for clinical planning [10]. In the investiga-
tions, both autoROBOT and autoVMAT plans were generated
for PTV3mm. AutoVMAT plans were also generated for PTV5mm,
as often applied for C-arm linac prostate SBRT. Average
PTV3mm and PTV5mm sizes were 91.2 cm
3 [57.8–142.3 cm3] and
109.5 cm3 [71.1–165.7 cm3], respectively.
Contoured OARs were rectum (outer contour), rectal
mucosa (3mm wall), bladder, urethra, femoral heads, scrotum
and penis. All plans simulated delivery of 38Gy in four frac-
tions, with highly heterogeneous dose distributions to emu-
late high dose-rate brachytherapy dosimetry [15].
Five patients were used for configuration of the autoROBOT
and autoVMAT planning systems (below). The automated
workflows were then applied to all 20 patients. For validation
of the autoROBOT planning system, autoROBOT plans for
the first 10 study patients were compared to the manually
generated and clinically delivered plans. For all 20 patients,
autoROBOT plans were compared with autoVMAT3mm plans
and autoVMAT5mm plans.
Automated plan generation
The autoVMAT and autoROBOT planning systems
Basis of autoROBOT and autoVMAT plan generation was the
Erasmus-iCycle multi-criterial optimizer for generating Pareto-
optimal and clinically favorable plans [18]. For practical and
legal reasons, Erasmus-iCycle plans cannot be directly used
clinically. However, we have recently coupled Erasmus-iCycle
to the Monaco treatment planning system (TPS) (Elekta AB,
Stockholm, Sweden) for fully automated, multi-criterial gener-
ation of IMRT and VMAT plans for clinical delivery at a linac;
based on the Erasmus-iCycle dose distribution, a patient-spe-
cific Monaco template is automatically produced, to be used
for automated final plan generation. Effectively, Erasmus-
iCycle first optimizes the plan, while Monaco converts it into
a clinically deliverable plan, see [19] for details. The resulting
plan quality is equal, or superior to the quality of manually
generated plans, and the system is now in routine clinical
use [19,28–31].
For this study, we have configured (see below) the system
for generating dual, full-arc autoVMAT plans for prostate SBRT
according to our clinical protocol, deliverable at an Elekta linac
equipped with an Agility MLC. Final plans were generated
with Monaco version 5.10 (Elekta AB, Stockholm, Sweden).
For automated multi-criterial generation of autoROBOT
plans, a special version of Erasmus-iCycle was prepared for
plan optimization for the IRIS variable aperture collimator
(Accuray AB, Sunnyvale, CA, USA), mounted on the CyberKnife.
Basis was a previously developed version for optimization with
fixed cone diameters and non-coplanar beam set-ups [32]. This
system was modified to handle the available non-coplanar
beam directions (nodes) of our novel M6 CyberKnife systems
and the IRIS collimator, i.e., 117 node positions from the full
body path. For fully automated generation of final, deliverable
plans, this Erasmus-iCycle version was coupled to the Multiplan
TPS (version 5.1.3) that comes with the CyberKnife, similar to
the system built for linacs (above). Similar to the linac solution,
automatically produced individualized planning templates were
used as intermediate between Erasmus-iCycle and Multiplan,
aiming at generating clinically deliverable plans that dosimetri-
cally mimicked the initial Erasmus-iCycle plans. As in clinical
practice, the goal was to keep the delivery time below 45min.
Apertures from 10 to 40mm diameter could be selected, as
used clinically for manually generated plans.
Configuration of autoVMAT and autoROBOT planning
As described above, both for autoVMAT and autoROBOT
planning, Erasmus-iCycle is used for plan optimization,
while the respective clinical planning systems are used for
mimicking the Erasmus-iCycle plan. Plan generation with
Erasmus-iCycle is based on a ‘wish-list’, containing the hard
planning constraints and planning objectives with their goal
values and assigned priorities [18]. For each treatment site/
treatment technique, a dedicated wish-list is configured,
which is then used for automated plan generation for all
involved patients, without further change.
In this study, a single wish-list was generated and applied
both for autoVMAT and autoROBOT planning.
Using the same wish-list for both techniques is a key
aspect of this study, since it allowed to perform a fair like for
like comparison of the two delivery techniques. Technical
details on the developed wish-list for prostate SBRT are pre-
sented in the Supplementary appendix.
Plan evaluation and comparison
In this study, plan comparisons were mainly focused on our
clinical aims. For the PTV, the near-minimum dose (D98%) and
the coverage (V100%) were evaluated. A coverage of 95% is
requested for clinical plans (V100%¼95%), while a coverage
between 93% and 95% is still acceptable if necessary to fulfill
OAR constraints. Rectum is considered the most important
OAR, focusing at the high doses with D1cm3<32.3 Gy. For
bladder, the D1cm3 requirement is <38Gy. Urethra D50% and
D5% constraint values are 40 and 45.5 Gy, respectively.
Apart from these clinically used plan parameters, we also
evaluated and compared Dmean for both rectum and bladder,
V40Gy and V60Gy (2 Gy/fx equivalent dose) for rectum, as sug-
gested by QUANTEC [33], as well as the dose bath, looking at
patient volumes receiving >30, >20, >10, >5 and >3Gy, as
5% of maximum dose.
When PTV coverage was achieved (>95%) for both plans,
the plan with the slightly higher coverage was re-normalized
to the value of the other plan. This approach minimized bias
in comparison of OAR doses, related to different PTV cover-
ages. Two-sided Wilcoxon’s signed-rank tests were performed
to compare plan parameters, using p<.05 as cut-off for statis-
tical significance.
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Apart from plan quality comparisons based on DVH met-
rics, for each patient, autoROBOT and autoVMAT plans were
also compared by the participating clinician (S.A.), who
scored quality differences using visual analogue scales (VASs)
as presented in section ‘Results’. PTV, rectum, bladder,
urethra and overall quality were scored separately. In total,
40 of these plan comparisons (20 patients; autoROBOT vs.
autoVMAT3mm and autoROBOT vs. autoVMAT5mm) were per-
formed in a random order. In each comparison, the two
plans were presented side-by-side to the clinician, who did
not know which plan was presented on the left and which
on the right of the screen (also here random ordering).
To investigate clinical deliverability of automatically generated
plans, dosimetric quality assurance (QA) was performed, as done
in our clinical routine. To this purpose, for five arbitrarily selected
patients, independent dose calculations were performed for
the autoROBOT plans, and measurements for autoVMAT plans
with 3 and 5mm margin. For the autoROBOT plans, beam direc-
tions and weights were used to recalculate the entire 3D dose
distribution with the Monte-Carlo dose computation software
SciMoCa (Scientific RT, Munich, Germany). For autoVMAT,
plans were delivered while irradiating a 2D-array in an Octavius
phantom (PTW, Freiburg, Germany). 3D (autoROBOT) and 2D
(autoVMAT) gamma analyses were performed with 5% cutoff,
3% global maximum dose and 1mm distance to agreement
(3%/1mm) criteria, and 95% passing rate threshold.
Results
autoROBOT vs. manual robotic planning
All manually and automatically generated plans for robotic
treatment fulfilled clinical requirements.
Automated planning improved plan quality compared to
the manually generated plans used for patient treatments, as
visible in population average DVHs in Figure 1. Differences in
PTV coverage were negligible (95.0% and 95.2% for manual
and autoROBOT plans (p¼.9)), but large differences in OAR
doses were observed; each patient plan improved with auto-
mated planning compared to manual planning. On average,
rectum D1cm3 was reduced from 31.2 to 26.3 Gy (16% reduc-
tion, p¼.002), V60Gy from 2.4 to 0.6% (75% reduction, p¼.002)
and rectum Dmean from 10.4 to 6.1 Gy (41% reduction,
p¼.002). Bladder Dmean was improved from 14.0 (manual
planning) to 6.1 Gy with automated planning (36% reduc-
tion, p¼.002).
autoROBOT vs. autoVMAT plan quality
autoROBOT vs. autoVMAT3mm
Both the autoROBOT and autoVMAT3mm plans with V100%>95%
could be generated for all patients, as visible in Table 1. The
near-minimum PTV dose was on average slightly higher for
autoROBOT plans and the CI was lower (Table 1, Figure 2(A)).
For the rectum (highest priority OAR), all parameters were
on average lower for the autoROBOT with reduction of 5% for
D1cm3 , 32% for V60GyEq, 22% for V40GyEq and 4% for Dmean
(Table 1, Figure 2(B)). Superiority in rectum dose parameters
was observed in 15–17 of the 20 study patients (Table 1),
where differences were considered to have real clinical impact
for eight patients (see clinical scoring below). For the 3–5
patients with a rectum dose advantage for autoVMAT3mm, the
differences with the robotic system were always small and
only for one patient considered clinically significant (see clin-
ical scoring below).
AutoVMAT3mm performed significantly better for bladder
Dmean, but the difference in the most important parameter,
D1cm3 , was small (1%) and statistically insignificant (Table 1).
Differences in urethra dose parameters were statistically
insignificant.
Figure 1. Population average DVHs for automatically generated robotic plans (autoROBOT, solid lines) and manually generated robotic plans (manual, dashed lines),
the latter used for patient treatment.
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For all patients, the autoROBOT was superior regarding
patient volumes receiving >5, >10, >20 and >30Gy (Table 1
and Figure 2(D)), with percentage mean differences of 12%
for V5Gy, 29% for V10Gy, 14% for V20Gy and 5% for V30Gy.
AutoVMAT3mm performed better for patient volumes receiv-
ing >3Gy, with mean percentage improvement of 12%.
Figure 3 shows axial dose distributions for patient 17, who
demonstrated the largest advantages for autoROBOT in rectum
plan parameters compared to autoVMAT (see also Figure 2(B)),
and for patient 13, with the largest rectum advantages for
VMAT. Apart from a better rectum sparing, in patient 17,
autoROBOT plan also showed better dose conformality, in
agreement with Figure 2(D).
All autoROBOT and autoVMAT3mm plans were clinically
acceptable for the participating clinician. The comparisons as
presented in the upper panel of Figure 4, are in line with the
plan parameter evaluations above. PTV doses were found of
equal quality for all patients. Apart from one patient with a
small advantage for autoVMAT3mm, rectum dose was consid-
ered equal or superior for autoROBOT. For bladder there was a
balance, with only equal plan quality or small differences
scored. For the urethra, the clinician had a slight preference for
the autoROBOT. Overall, for 13 patients the clinician preferred
autoROBOT, for two patients he preferred the autoVMAT3mm
plan, and for five patients he scored equal quality.
autoROBOT vs. autoVMAT5mm
While for autoROBOT and autoVMAT3mm, a PTV coverage
95% was obtained for all 20 patients, with autoVMAT5mm
this was only achieved for two patients, due to OAR
constraints. Seven other patients obtained a clinically still
acceptable coverage between 95% and 93%, while for the
remaining 11 patients coverage was clinically unacceptable
(<93%), with a minimum of 88.8%. Also the near-minimum
PTV doses were lower in the autoVMAT5mm plans, while the
CI was higher.
Notwithstanding the lower PTV coverage for autoVMAT5mm,
rectum sparing was also unfavorable compared to autoROBOT,
with mean percentage differences of 13% for rectum D1cm3 ,
69% for V60GyEq, 58% for V40GyEq and 32% for Dmean.
Differences in bladder and urethra plan parameters were stat-
istically insignificant. Dose bath was also favorable for
autoROBOT plans, with reductions of patient irradiated vol-
umes of 19% for V5Gy, 37% for V10Gy, 25% for V20Gy and 18%
for V30Gy. V3Gy was 5% lower for autoVMAT5mm, but this
was not statistically significant. Details on the comparisons
between autoROBOT and autoVMAT5mm are presented in the
right part of Table 1 and Figure 2(E–H). Favorable plan quality
for autoROBOT compared to autoVMAT5mm is also observed in
Figure 3 (right panels) and superiority of autoROBOT was also
confirmed by the clinician scoring (Figure 4, lower panel).
For all 20 patients, the overall quality of the autoROBOT
plans was considered better than for autoVMAT5mm. For 11
patients, the clinician expected a real clinical impact of
choosing the autoROBOT plan instead of the autoVMAT5mm
plan, for other eight patients a possibly important impact
was expected, and for one patient a quality gain with prob-
ably low impact was scored.
Dosimetric QA
All plans passed the QA tests, with average gamma passing
rates of 98.7 ± 0.6% for autoROBOT, 99.8 ± 0.2% for
autoVMAT3mm and 99.6 ± 0.8% for autoVMAT5mm.
Table 1. For all 20 patients, comparisons of autoROBOT with autoVMAT3mm and autoVMAT5mm plans.
autoVMAT3mm autoVMAT5mm
autoROBOT VMAT – ROBOT (%)a VMAT – ROBOT (%)
Mean (range) Mean Mean (range) p #Ptsb Mean Mean (range) p #Pts
PTV
V100% (%) 95.2 (95.0,95.5) 95.3 0 (–1,0) .3 8 92.7 3 (0,7) <.001 20
D98% (Gy) 36.1 (35.2,36.9) 35.8 1 (–2,3) .01 13 33.7 7 (3,13) <.001 20
CIc 1.1 (1.1,1.1) 1.2 6 (3,10) <.001 20 1.2 6 (2,10) <.001 20
Rectum
D1cm3 (Gy) 28.0 (23.0,33.5) 29.4 5 (–3,18) .002 16 32.2 13 (1,23) <.001 20
V60GyEq (%) 1.1 (0.3, 2.6) 1.5 32 (–26,77) .001 17 3.3 69 (15,89) <.001 20
V40GyEq (%) 3.8 (1.9, 6.0) 4.9 22 (–13,56) <.001 17 9.2 58 (24,76) <.001 20
Dmean (Gy) 6.3 (4.2, 7.7) 6.6 4 (–18,25) .05 15 9.3 32 (14,45) <.001 20
Bladder
D1cm3 (Gy) 37.4 (36.4,39.1) 37.2 –1 (–6,2) .3 9 37.6 0 (–3,3) .4 12
Dmean (Gy) 9.7 (6.5,13.0) 8.4 –18 (–45,7) <.001 2 9.3 –6 (–32,15) .1 7
Urethra
D5% (Gy) 40.4 (39.4,42.3) 40.9 1 (–4,6) .06 13 41.6 3 (–3,8) .001 17
D50% (Gy) 38.3 (37.5,39.2) 38.5 1 (–3,3) .2 14 39.1 2 (–1,6) <.001 17
Patient
V3Gy (cm
3) 4910 (3428,7064) 4378 –12 (–30,11) .001 4 4669 –5 (–22,16) .05 6
V5Gy (cm
3) 3143 (2147,4779) 3538 12 (–5,28) <.001 18 3864 19 (3,35) <.001 20
V10Gy (cm
3) 1137 (737,1872) 1583 29 (19,37) <.001 20 1789 37 (24,47) <.001 20
V20Gy (cm
3) 293 (203,442) 342 14 (5,20) <.001 20 392 25 (17,34) <.001 20
V30Gy (cm
3) 150 (103,229) 159 5 (0, 9) <.001 20 182 18 (12,24) <.001 20
aPercentage differences are expressed as 6j100  ðautoVMAT autoROBOTÞ=autoVMATj with positive differences representing better perform-
ance for robotic.
bNumber of patients with superior plan parameter quality for robotic treatment.
cCI: conformity index (¼patient volume receiving the prescribed dose/PTV volume receiving prescribed dose).
ACTA ONCOLOGICA 1493
Discussion
In this study, we have presented the first system for fully
automated generation of clinically deliverable treatment
plans for a commercial robotic treatment unit. Automated
planning, including non-coplanar beam angle selection,
showed to improve plan quality, compared to manual plan-
ning. With equal PTV coverage, autoROBOT plans were
superior to manual plans for all patients in sparing of the rec-
tum and bladder, with negligible (but still superior) differen-
ces for all other clinical requirements. These findings are in
line with results that we obtained on automated planning
for regular linacs, using a similar approach for automatic
plan generation, see section ‘Material and methods’ and
[19,28,29,31]. Apparently, interactive, manual planning is so
Figure 2. For all 20 patients, differences between autoROBOT and autoVMAT3mm (left panels), or autoVMAT5mm (right panels), expressed as 6jautoVMAT
autoROBOTj with positive values representing better quality for autoROBOT. For dose bath percentage differences as 6j100  ðVMAT ROBOTÞ=VMATj are
expressed to compensate for differences in volumes (cm3) range between parameters. CI: conformity index (¼patient volume receiving 38 Gy/PTV receiving 38 Gy).
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complex and dependent on the planners’ skills and allotted
planning time, that an optimal planning solution can often
not be guaranteed. The applied wish-list approach for
automated planning features for each individual patient a
systematic search for finding the dosimetric parameters of
a Pareto-optimal plan with clinically desirable trade-offs
between all objectives. A commercial planning system is
then used to realize a clinically deliverable plan, using the
attained plan parameters as constraints, without any further
trial-and-error planning. As described in [18] and the
Electronic Appendix, a wish-list for a treatment site is devel-
oped based on the clinical treatment protocol and a few
(typically 5) plans of recently treated patients. A wish-list con-
figuration entails repeated automatic plan generations for
the five patients, each time followed by an update of the
wish-list that aims at a still higher plan quality in the next
iteration. This iterative process is stopped if further improve-
ments are considered not feasible. Specifically advantageous
for autoROBOT planning, the upfront knowledge of feasible
constraints allows the use of high resolution optimization
grid in the commercial TPS for generating the deliver-
able plan.
Also for other systems, improvements in VMAT/IMRT plan
quality by using automated planning have been reported
[34,35]. Nelms et al. [36] observed large plan quality varia-
tions between 125 manual planners from various institutes,
even with a very detailed and quantitative description of
planning goals. Berry et al. showed large inter-planner
variations in quality of plans that were manually generated
within a single institution. Automated planning assisted in
reducing the variations [37,38]. Clearly, further investigations
on inconsistencies in manual planning and the potential role
for automated planning are warranted.
Strong points of our comparison of robotic surgery with
VMAT for prostate SBRT are (i) the use of validated auto-
mated multi-criterial planning for both techniques (validation
by systematic comparison with manual planning, see [19] for
autoVMAT and the Results section for autoROBOT) and (ii)
the use of the same TPS and exactly the same optimization
scheme for initial plan optimization for the two techniques
(wish-list, see section ‘Material and methods’). Due to these
features, a bias-free comparison between robotic treatment
and VMAT could be made, based on consistent, high qual-
ity plans.
Technique comparisons were performed using dosimet-
ric (DVH) evaluations and by blind side-by-side plan scor-
ing by the clinician responsible for prostate SBRT in our
center. The clinician scoring has important added value
compared to dosimetric analyses only, as it gives inte-
grated views, considering the full dose distribution to
OARs and PTV and the global clinical quality of the plan
for each individual patient. In a clinical setting, a clinician
would never accept a plan comparison that is only based
on DVH parameters.
AutoROBOT plans showed significant advantages com-
pared to autoVMAT, both in the DVH analyses and the clin-
ician’s scoring. This was found for equal, 3mm, CTV-PTV
margins, and even stronger when comparing autoROBOT
plans with 3mm margin with autoVMAT plans with 5mm
margin. For 11 of the 20 patients, the autoVMAT plan with
5mm margin was clinically unacceptable because of low PTV
coverage (<93%). On top of that, rectum, bladder and
urethra doses were significantly higher compared to
autoROBOT. For all patients, the autoROBOT plan had a
largely reduced dose bath compared to both autoVMAT3mm
and autoVMAT5mm. The latter may especially be important for
Figure 3. Axial dose distributions for autoROBOT, autoVMAT3mm and autoVMAT5mm, for patients 17 (upper panels) and 13 (lower panels). These patients demon-
strated the most pronounced advantage in rectum dose for autoROBOT instead of autoVMAT (patient 17), and the most pronounced advantage using autoVMAT
compared to autoROBOT (patient 13) (see also Figure 2(B,F)). Red contour: PTV (3mm or 5mm), orange contour: rectum, blue contour: bladder and yellow con-
tour: urethra.
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avoidance of secondary tumors in the increasing fraction of
younger prostate cancer patients, related to PSA screening.
A limitation of the study is that we did not clinically com-
pare robotic treatment with VMAT, as needed for final con-
clusions, which we considered out of the scope of this paper.
Another (practically unavoidable) limitation is that the
autoVMAT and autoROBOT plans were calculated with differ-
ent dose calculation engines as implemented in the corre-
sponding TPS. Although both systems were thoroughly
tested prior to clinical introduction, this might cause some
bias in the comparisons.
Neither of the two recent studies that compared robotic
treatment and VMAT for prostate SBRT [16,17] observed the
potential of a large plan quality improvement for robotic
treatment, as observed in our study. Both the manual plan-
ning and retrospective plan comparisons, as used in these
studies, may have introduced bias in the technique compari-
sons. MacDougall et al. [16] used a 3mm CTV-PTV margin for
robotic treatment and a 5mm margin for VMAT, and found
no discernible dosimetric differences based on only six
patients. Lin et al. [17] used a 3mm margin for robotic treat-
ment and for VMAT 5mm in all directions, except 3mm in
posterior direction. They concluded that VMAT was prefer-
able because of reduced treatment time and superior dose
distribution conformality. The study showed however large
and systematic differences between robotic treatment and
VMAT in PTV dose inhomogeneity and PTV coverage, which
could have influenced the conclusions.
Dong et al. compared VMAT with non-coplanar treatment
at a C-arm linac [14], using with the 4p non-coplanar delivery
approach involving both gantry rotations and couch displace-
ments. For both techniques, the CTV-PTV margin was 5mm
with a reduction to 3mm toward the rectum. As in our study,
they observed clear plan quality advantages for non-coplanar
treatment compared to coplanar VMAT. Automated plan gen-
eration was however only used for the non-coplanar plan-
ning, which could possibly have introduced some bias in the
comparisons, favoring non-coplanar treatment. For robotic
couch translations and rotations, Linthout et al. [39] observed
patient motion of up to 3mm and 2. Nonetheless, Dong
et al. [14] used the same CTV-PTV planning margin for VMAT
and non-coplanar treatment, possibly resulting in some study
bias in favor of non-coplanar linac treatment. In our study,
we investigated isotropic 3mm and 5mm CTV-PTV margins
for autoVMAT. As our autoROBOT plans were already superior
to VMAT with isotropic 3mm margins, the same (and prob-
ably to a larger extent) is expected to hold for 5mm margins
with a reduction to 3mm toward the rectum.
Figure 4. Visual analogue scale (VAS) used for blind side-by-side plan comparisons by the treating clinician, and clinician scoring with the values representing num-
bers of plans (for each line, the sum values equal to 20).
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Delivery times of the autoROBOT plans generated in this
study were around 45min (section ‘Material and methods’),
as used in our clinical practice for treatment with an IRIS
variable aperture collimator, while VMAT treatments times
were much shorter (8–10min). Most of the VMAT5mm plans
were clinically unacceptable, and robotic treatment would
anyway be preferable, also with the prolonged treatment
time. For the other VMAT5mm plans, quality gains with
robotic have to be weighed against the prolonged treatment
duration. The same holds for VMAT3mm plans, that might be
applicable at linacs with novel systems for intra-fraction
motion correction [11,13]. In this study, we have generated
robotic plans for the variable aperture IRIS collimator.
Currently, an MLC is available for the investigated robotic
treatment unit [40,41], probably resulting in reduced delivery
times [42–45].
As described in section ‘Material and methods’, for robotic
prostate SBRT plans, we try to mimic HDR brachytherapy
dose distribution with intentionally inhomogeneous PTV dose
delivery, with high peak doses inside the PTV. The urethra
dose is minimized by dose–volume constraints. As the robot
corrects for rotational tumor displacements, no PRV planning
margin around the urethra is clinically used. C-arm linacs are
not equipped with a system for rotation correction, implying
that a PRV margin around the urethra may be needed for
the inhomogeneous dose distributions studied in this paper.
This could then possibly result in an enhanced percentage of
patients with an unacceptably low PTV coverage. The need
and implications of the use of a urethra PRV margin at a C-
arm linac have not been investigated in this study.
Conclusions
The first system for fully automated generation of clinically
deliverable plans for non-coplanar robotic treatment has
been presented. The system features multi-criterial beam pro-
file and beam angle optimization, resulting in plans with clin-
ically favorable trade-offs between all treatment aims. For
prostate SBRT, clinically acceptable, high quality plans could
be generated that highly outperformed manually generated
plans. Automatically generated robotic plans had consistently
higher quality than automatically generated plans for VMAT
at a linac. Further research on improvement of plan quality
and plan consistency, including the role of automated plan-
ning, is warranted.
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